Shareholders’ equity

3 Months Ended

Oct. 31, 2025

Equity [Abstract]

Shareholders’ equity

Stockholders’ equity

The following table presents a summary of the Company’s share activity:

	Three months ended
	October 31,
	2025	2024
Ordinary shares:
Balance at beginning of period	—	232,171,182
Treasury shares canceled	—	(30,827,929)
Ordinary shares canceled	—	(201,343,253)
Balance at end of period	—	—
Common stock:
Balance at beginning of period	201,343,253	—
Common stock issued	—	201,343,253
Balance at end of period	201,343,253	201,343,253
Treasury shares:
Balance at beginning of period	(4,759,053)	(30,827,929)
Treasury shares canceled	—	30,827,929
Share repurchases	(901,308)	(1,310,163)
Treasury shares used to settle share-based compensation awards	212,660	248,690
Balance at end of period	(5,447,701)	(1,061,473)
Total shares outstanding at end of period	195,895,552	200,281,780

Share Repurchases

The Company is currently purchasing shares under an authorization that allows up to $5.0 billion in share repurchases. As of October 31, 2025, the Company had completed $4.2 billion in share repurchases under the authorized program.

Ordinary Shares and Treasury shares

As of August 1, 2024, the Company canceled all ordinary shares in connection with its completion of the transaction to establish a new corporate structure to domicile our parent company in the United States. As a result, in the first quarter of fiscal 2025, 30,827,929 ordinary shares held in treasury were canceled, 201,343,253 of outstanding ordinary shares not held in treasury were canceled and 201,343,253 shares of common stock were issued as consideration therefor.